This annual forum, scheduled for February 12, 2026, at the University of California San Francisco (UCSF), is dedicated to exploring the transformative potential of impact investing in addressing challenges related to rare diseases. The event highlights the critical roles of venture philanthropy and innovative collaborations in advancing therapies. By strategically mobilizing funding and partnerships, the conference seeks to accelerate the commercialization of treatments that hold the promise of revolutionizing care for patients with rare diseases.

The summit brings together a diverse group of investment professionals, venture leaders, patient advocates, researchers, and entrepreneurs. Attendees will learn cutting-edge approaches to funding breakthrough therapies and gain insights into advancing translational research through strategic collaboration. The program features main-stage sessions, panel discussions, and ample high-level networking opportunities designed to foster connections and drive the development of new cures.